Site icon OncologyTube

Baseline Low B-value Diffusion-weighted Magnetic Resonance Imaging is Prognostic in Metastatic Renal Cell Carcinoma and Correlates with Dynamic Contrast-enhanced Ultrasound and Dynamic …

Jill Rachel Mains, MD, Dept. of Radiology and Oncology, Aarhus University Hospital presents Baseline Low B-value Diffusion-weighted Magnetic Resonance Imaging is Prognostic in Metastatic Renal Cell Carcinoma and Correlates with Dynamic Contrast-enhanced Ultrasound and Dynamic Contrast-enhanced Computed Tomography: Results from the DARENCA-1 Study at the 2016 annual International Kidney Cancer Symposium.

Exit mobile version